EECP – Enhanced External Counter Pulsation
EECP Therapy (Enhanced External Counter Pulsation) is seen as a good alternative to treat coronary artery blockage which otherwise is subjected to Drugs, Angioplasty, Stent and Bypass Surgery. This is the ‘only’ non-invasive and non-pharmaceutical treatment approved by USFDA. During this treatment, BP like cuffs around the legs and buttocks are inflated and deflated at specific intervals between the heartbeats. A continuous ECG is used to set timing so that the cuffs inflate when heart is at rest, when it normally gets blood supply and oxygen. The cuffs deflate at the end of rest period just before their next heartbeat. A special sensor applied to the finger checks oxygen level in blood and monitors the pressure waves created by inflations and deflations. EECP uses patents own blood to stimulate new vessel formation around blocked arteries. EECP treatment triggers and accelerates collateral circulation and even makes it permanent. Collateral circulation is nothing but formation of tiny blood vessels which make it possible for blood to detour around blocked vessels or narrowed arteries. Clinical improvements can be observed between 15-20 sessions of the total 35 sessions of one hour each. The benefits are not limited to an increase in overall energy levels, decrease in angina or shortness of breath, reduced or stoppage of nitroglycerin medication.
EECP is a product of Vascomedical USA which has a patent on the timing mechanism of the system (Microsecond precise timing when the cuff inflates and deflates). Visit our partners page for more information.
Tuberclosis(TB) being the infectious disease is communicated almost exclusively by coughed aerosols carrying pathogens of Mycobacterium tuberclosis (Mtb). As reported by World Health Organization (WHO) it causes disease in 9.6 millions people each year and ranks with human immunodeficiency virus (HIV) as a leading cause of disease. A well timed diagnosis and appropriate treatment can […]Read More »
A researcher at Moffitt Cancer Center and his international team of colleagues have reported study results on a novel multireceptor-targeted somatostatin analogue called pasireotide (SOM230) manufactured by Novartis Pharma AG. The Phase II, open-label, multicenter study in patients with advanced neuroendocrine tumors (NET) whose symptoms were no longer responsive to octreotide LAR therapy found that […]Read More »
In a large epidemiologic study, researchers at UCLA’s Jonsson Cancer Center found that the children of U.S.-born Latina women are at higher risk of having retinoblastoma, a malignant tumor of the retina which typically occurs in children under six. The study, which focused on babies born in California, also found that offspring of older fathers […]Read More »
Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles. Soot particles are dangerous – there is nothing new in this knowledge. […]Read More »
A new clinical trial published in the August edition of Clinical Cancer Research has revealed that cancer patients who drink one glass of grapefruit juice per day achieve the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself. It could also help […]Read More »
On 14 February 2012, the German Institute for Quality and Efficiency in Health Care (IQWiG) published the results of a literature search for evidence-based clinical practice guidelines on the treatment of people with heart failure. The aim of the report is to identify those recommendations from current guidelines of high methodological quality that may be […]Read More »
When combined with standard diagnostic tests, functional imaging procedures have been shown to reduce the rate of misdiagnosed cases of infectious endocarditis. According to new research published in the August issue of The Journal of Nuclear Medicine, single photon emission computed tomography (SPECT)/computed tomography (CT) with 99mTc-hexamethylpropleneamine oxime-labeled white blood cells (99mTc-HMPAO-WBC) can improve the […]Read More »
For years, scientists have been looking for a good source of heart cells that can be used to study cardiac function in the lab, or perhaps even to replace diseased or damaged tissue in heart disease patients. To do this, many are looking to stem cells. Researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), the Human […]Read More »
A new genetic analysis focusing on Jews from North Africa has provided an overall genetic map of the Jewish Diasporas. The findings support the historical record of Middle Eastern Jews settling in North Africa during Classical Antiquity, proselytizing and marrying local populations, and, in the process, forming distinct populations that stayed largely intact for more […]Read More »
University of Minnesota School of Public Health researchers have found that medical group practices can reduce costs for patients with diabetes by investing in improved quality of care. In the study, which appears in the August issue of Health Affairs, University of Minnesota researchers analyzed 234 medical group practices providing care for more than 133,000 […]Read More »